EVIDENCE: A Non-Interventional Study of Treatment and Clinical Outcomes in Chinese Patients With Gastric Cancer
Conditions
Gastric Cancer
Conditions: official terms
Stomach Neoplasms
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Recruiting
Summary
This prospective, multi-center, non-interventional study will evaluate the efficacy and safety of Herceptin (trastuzumab) in routine clinical practice in Chinese patients with gastric or gastro-oesophageal cancer. Treatment patterns and clinical outcomes in patients with gastric cancer in China will be evaluated. Data will be collected from eligible patients for up to 6 years.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Histologically confirmed cancer of the stomach or gastro-oesophageal junction or recurrent disease within 6 months before the date of recruitment

- Documented patient with trackable medical records

- HER2 IHC status is known

- Cohort I/II/IV:

Patients with mGC: with recurrent or metastatic disease or with inoperable locally advanced disease

- Cohort III/V:

Patients with operable non-mGC: TxNxM0 (according to AJCC edition 7th)

Exclusion Criteria:

- Patients receiving regimen in a blinded trial
Locations
Anyang, China
Status: Recruiting
Beijing, China
Status: Recruiting
Beijing, China
Status: Recruiting
Beijing, China
Status: Not yet recruiting
Beijing, China
Status: Recruiting
Beijing, China
Status: Recruiting
Beijing, China
Status: Recruiting
Beijing, China
Status: Recruiting
Beijing, China
Status: Recruiting
Beijing, China
Status: Not yet recruiting
Changchun, China
Status: Recruiting
Changsha, China
Status: Recruiting
Changsha, China
Status: Recruiting
Changzhou, China
Status: Recruiting
Chengdu, China
Status: Recruiting
Chengdu, China
Status: Recruiting
ChongQing, China
Status: Recruiting
Foshan, China
Status: Recruiting
Fu Zhou, China
Status: Recruiting
Fujian, China
Status: Recruiting
Fuzhou, China
Status: Recruiting
Guangzhou, China
Status: Recruiting
Guangzhou, China
Status: Recruiting
Guangzhou, China
Status: Recruiting
Guiyang, China
Status: Recruiting
Guiyang, China
Status: Recruiting
Haikou, China
Status: Recruiting
Hangzhou, China
Status: Recruiting
Hangzhou, China
Status: Recruiting
Harbin, China
Status: Recruiting
Hefei, China
Status: Recruiting
Hohhot, China
Status: Recruiting
Hohhot, China
Status: Recruiting
Jinan, China
Status: Not yet recruiting
Kunming, China
Status: Recruiting
Kunming, China
Status: Recruiting
Lanzhou, China
Status: Recruiting
Lanzhou, China
Status: Recruiting
Linhai, China
Status: Recruiting
Luoyang, China
Status: Recruiting
Nanchang, China
Status: Recruiting
Nanchang, China
Status: Recruiting
Nanchong, China
Status: Recruiting
Nanjing, China
Status: Recruiting
Nanjing, China
Status: Recruiting
Nanjing, China
Status: Recruiting
Nanjing, China
Status: Recruiting
Nantong, China
Status: Recruiting
Nantong, China
Status: Recruiting
Qingdao, China
Status: Recruiting
Shanghai, China
Status: Recruiting
Shanghai, China
Status: Recruiting
Shanghai, China
Status: Recruiting
Shanghai, China
Status: Recruiting
Shaoxing, China
Status: Recruiting
Shenyang, China
Status: Recruiting
Shijiazhuang, China
Status: Recruiting
Suzhou, China
Status: Recruiting
Taiyuan, China
Status: Recruiting
Tianjin, China
Status: Recruiting
Urumqi, China
Status: Recruiting
Urumqi, China
Status: Recruiting
Wenzhou, China
Status: Recruiting
Wuhan, China
Status: Recruiting
Wuhan, China
Status: Recruiting
Wuhan, China
Status: Recruiting
Wuhan, China
Status: Recruiting
Wuxi, China
Status: Recruiting
Xi'an, China
Status: Recruiting
Xi'an, China
Status: Recruiting
Xiamen, China
Status: Recruiting
Xiamen, China
Status: Recruiting
Xian, China
Status: Recruiting
Xinxiang, China
Status: Recruiting
Yangzhou, China
Status: Recruiting
Zhangzhou, China
Status: Recruiting
Zhengzhou, China
Status: Recruiting
Zhengzhou, China
Status: Recruiting
Zhengzhou, China
Status: Recruiting
Zhenjiang, China
Status: Recruiting
Start Date
April 2013
Completion Date
June 2018
Sponsors
Hoffmann-La Roche
Source
Hoffmann-La Roche
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page